GlassScriptPhysician profile
Jamie Bair
NPI 1275800252
$2,237.79
in general payments reported to CMS, 2019-2025
21 companies · $478 in 2025
The $478 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $214 · 2022: $647 · 2023: $498 · 2024: $400 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,376.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $503.73 | 2021-2025 | Triclip, Aveir |
| Edwards Lifesciences Corporation | $175.59 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Impulse Dynamics (USA) INC. | $168.63 | 2022 | |
| Alnylam Pharmaceuticals INC. | $162.59 | 2022-2024 | Amvuttra |
| Merck Sharp & Dohme LLC | $147.59 | 2024-2025 | Verquvo |
| Biosense Webster, INC. | $128.06 | 2025 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $118.11 | 2024 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.01 | 2022-2024 | Lifevest |
| Philips North America LLC | $105.35 | 2023 | |
| Kestra Medical Technology Services, INC. | $90.46 | 2023-2025 | Assure Wcd |
| Medtronic, INC. | $79.13 | 2021-2025 | Venaseal |
| Pfizer INC. | $74.80 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $73.93 | 2021-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.41 | 2021-2025 | Jardiance |
| Terumo Medical Corporation | $62.99 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $62.99 | 2022 | |
| Atricure, INC. | $24.93 | 2022 | |
| Amarin Pharma, INC. | $19.91 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $19.03 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $18.58 | 2025 | |
| Cvrx, INC. | $15.97 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Bair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.